APA (7th ed.) Citation

Gorodnova, T. V., Sokolenko, A. P., Kotiv, K. B., Sokolova, T. N., Ivantsov, A. O., Guseynov, K. D., . . . Imyanitov, E. N. (2021). Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin. Hereditary Cancer in Clinical Practice, 19(1), 1. https://doi.org/10.1186/s13053-021-00173-2

Chicago Style (17th ed.) Citation

Gorodnova, Tatiana V., et al. "Neoadjuvant Therapy of BRCA1-driven Ovarian Cancer by Combination of Cisplatin, Mitomycin C and Doxorubicin." Hereditary Cancer in Clinical Practice 19, no. 1 (2021): 1. https://doi.org/10.1186/s13053-021-00173-2.

MLA (9th ed.) Citation

Gorodnova, Tatiana V., et al. "Neoadjuvant Therapy of BRCA1-driven Ovarian Cancer by Combination of Cisplatin, Mitomycin C and Doxorubicin." Hereditary Cancer in Clinical Practice, vol. 19, no. 1, 2021, p. 1, https://doi.org/10.1186/s13053-021-00173-2.